Pharma News: Mirati starts dosing in Phase II trial of mocetinostat to treat non-Hodgkin's lymphoma http://t.co/ruUS9e98kJ
— Pharma Industry News (@PharmaNewsDaily) January 7, 2015
from Twitter http://ift.tt/11Cavy0
January 07, 2015 at 04:46AM
via IFTTT
No comments:
Post a Comment